Advances in Women's Health

Are PARP Inhibitors the Future of Treating Triple-Negative Breast Cancer?

10.18.2019 - By ReachMDPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Host: Matt Birnholz, MD

Guest: Hans Petter Eikesdal, MD

At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

More episodes from Advances in Women's Health